Asia

High-quality medicines developed to meet the therapeutic needs of today and tomorrow.

For more than 30 years, PHARMA Développement has been developing, manufacturing, and marketing medications that meet the highest standards of quality, safety, and efficacy.

Supporting patients and healthcare professionals is at the heart of our commitment. Our portfolio spans several therapeutic areas, enabling us to offer solutions tailored to the needs of the French and international markets, in compliance with regulatory requirements and with a constant focus on innovation.

Since 1991, our pharmaceutical and industrial expertise has enabled us to develop reliable, accessible medications recognized for their quality, thereby helping to improve patients’ comfort and quality of life.

The list of medications varies by region and is therefore not the same from one geographic area to another. It is also subject to change over time.

  • FLUCOLENE 150 mg

    Therapeutic Area Parasitology

    • Dry

    Principes actifs Fluconazole

  • FLUCOLENE 200 mg

    Therapeutic Area Parasitology

    • Dry

    Principes actifs Fluconazole

  • ITRADERMA 100 mg

    Therapeutic Area Parasitology

    • Adults
    • Dry

    Principes actifs Itraconazole

  • KLARISTAT 250 mg / 5 mL Powder for Suspension

    Therapeutic Area Parasitology

    • Dry

    Principes actifs Clarithromycin

  • ULTRAVIR 200 mg / 5 ml

    Therapeutic Area Parasitology

    • Dry

    Principes actifs Acyclovir

  • DOLFLAM 1% Gel

    Therapeutic Area Rheumatology

    • Pasty

    Principes actifs Diclofenac sodium

  • DOLFLAM 50 mg Film-coated tablets

    Therapeutic Area Rheumatology

    • Dry

    Principes actifs Diclofenac Potassium

  • PREDNABENE 5 mg Tablets

    Therapeutic Area Rheumatology

    • Dry

    Principes actifs Prednisolone

  • PREDNABENE 15 mg / 5 ml – 100 ml

    Therapeutic Area Rheumatology

    • Liquids

    Principes actifs Prednisolone

  • PREDNABENE 20 mg

    Therapeutic Area Rheumatology

    • Dry

    Principes actifs Prednisolone

  • QUENIL 200 mg

    Therapeutic Area Rheumatology

    • Dry

    Principes actifs Hydroxychloroquine sulfate

Report

Do you wish to make a report?

In accordance with legal and regulatory obligations governing health and safety, you can report any adverse event (medicinal or cosmetic) or suspected quality defect related to the use of one of our products.

This information is crucial for the ongoing evaluation of our safety profile. Please submit your report: directly to our monitoring department via the contact form for medications; and/or via our telephone number +33 (0)3 86 20 21 64.